Stock Earnings

Question 1

What are Maze Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Maze Therapeutics Inc has a total asset of $240, Net profit of $3

Question 2

What are the key financial ratios for MAZE?

Accepted Answer

Maze Therapeutics Inc's Current ratio is 5.58, has a Net margin is 1.79, sales per share of $3.81.

Question 3

How is Maze Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Maze Therapeutics Inc data is not available.

Question 4

Is Maze Therapeutics Inc profitable?

Accepted Answer

yes, according to the latest financial statements, Maze Therapeutics Inc has a net profit of $3

Question 5

Does Maze Therapeutics Inc have any liabilities?

Accepted Answer

yes, Maze Therapeutics Inc has liability of 43

Question 6

How many outstanding shares for Maze Therapeutics Inc?

Accepted Answer

Maze Therapeutics Inc has a total outstanding shares of 43.77

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022
Revenue	2	167	0	0
Revenue Growth (YoY)	--	--	--	--
Cost of Revenue	--	--	--	--
Gross Profit	--	--	--	--
Selling, General & Admin	22	26	24	22
Research & Development	70	83	73	88
Operating Expenses	92	109	98	111
Other Non Operating Income (Expenses)	--	--	--	--
Pretax Income	-88	53	-100	-114
Income Tax Expense	0	1	--	--
Net Income	-41	3	-100	-114
Net Income Growth	--	-103%	-12%	--
Shares Outstanding (Diluted)	43.79	43.77	43.77	43.77
Shares Change (YoY)	--	0%	0%	--
EPS (Diluted)	-0.93	0.07	-2.29	-2.62
EPS Growth	--	-103%	-13%	--
Free Cash Flow	-106	74	-87	-101
Free Cash Flow Per Share	-2.42	1.69	-1.98	-2.3
Gross Margin	--	--	--	--
Operating Margin	-4,500%	34.13%	0%	0%
Profit Margin	-2,050%	1.79%	0%	0%
Free Cash Flow Margin	-5,300%	44.31%	0%	0%
EBITDA	-88	60	-94	-108
EBITDA Margin	-4,400%	35.92%	0%	0%
D&A For EBITDA	2	3	4	3
EBIT	-90	57	-98	-111
EBIT Margin	-4,500%	34.13%	0%	0%
Effective Tax Rate	0%	1.88%	--	--

Maze Therapeutics Inc (MAZE) Price